advertisement
Guo L 96
Showing records 1 to 25 | Display only abstracts from Guo L in IGR 20-2108137 Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement
Liu M
American Journal of Ophthalmology 2023; 252: 205-212 (IGR: 23-4)
107977 The alterations of brain network degree centrality in patients with neovascular glaucoma: a resting-state fMRI study
Wang Y; Wang R
Neurological Sciences 2023; 44: 2915-2922 (IGR: 23-4)
108137 Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement
Wen H; Lin L; Ge C
American Journal of Ophthalmology 2023; 252: 205-212 (IGR: 23-4)
107977 The alterations of brain network degree centrality in patients with neovascular glaucoma: a resting-state fMRI study
Guo L; Zhan Y
Neurological Sciences 2023; 44: 2915-2922 (IGR: 23-4)
108137 Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement
Guo L
American Journal of Ophthalmology 2023; 252: 205-212 (IGR: 23-4)
107977 The alterations of brain network degree centrality in patients with neovascular glaucoma: a resting-state fMRI study
Duan F
Neurological Sciences 2023; 44: 2915-2922 (IGR: 23-4)
108137 Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement
Chodosh J
American Journal of Ophthalmology 2023; 252: 205-212 (IGR: 23-4)
107977 The alterations of brain network degree centrality in patients with neovascular glaucoma: a resting-state fMRI study
Cheng J
Neurological Sciences 2023; 44: 2915-2922 (IGR: 23-4)
108137 Short-Term Outcomes of Modified Boston Type-II Keratoprosthesis Implantation With Autologous Auricular Cartilage Reinforcement
Zheng Q; Chen W
American Journal of Ophthalmology 2023; 252: 205-212 (IGR: 23-4)
107977 The alterations of brain network degree centrality in patients with neovascular glaucoma: a resting-state fMRI study
Tang Z
Neurological Sciences 2023; 44: 2915-2922 (IGR: 23-4)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Li S
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Zhao S
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Guo L
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Fang L; Yan C
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhou P; Tang J
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Wei J; Song D
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Wang Z
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Xu C
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhang L
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Luo Y
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
106511 Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Zhao M; Qu J
Eye and vision (London, England) 2022; 9: 44 (IGR: 23-3)
106737 MicroRNA-210-3p mediates trabecular meshwork extracellular matrix accumulation and ocular hypertension - Implication for novel glaucoma therapy
Fan Y; Guo L; Sun H; Guo T
Experimental Eye Research 2023; 227: 109350 (IGR: 23-3)
100645 Scleral Cross-Linking in Form-Deprivation Myopic Guinea Pig Eyes Leads to Glaucomatous Changes
Guo L; Hua R; Zhang X; Yan TY; Tong Y; Zhao X; Chen SC; Wang M; Bressler NM; Kong J
Investigative Ophthalmology and Visual Science 2022; 63: 24 (IGR: 23-1)
96508 Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension
Huang Y; Guo L; Zhang Y; Zhao M; Xue F; Tan C; Huang J; Chen D
CNS and Neurological Disorders - Drug Targets 2021; 20: 285-297 (IGR: 22-3)
95045 Zinc oxide nanoparticle-triggered oxidative stress and autophagy activation in human tenon fibroblasts
Guo D
European Journal of Pharmacology 2021; 907: 174294 (IGR: 22-2)